Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
| Country | United States |
|---|---|
| Deadline | 2027-02-11 (81 days left) |
| Published | 2026-10-13 |
| Sectors | Health & life sciences, Research & innovation |
| Source | Grants.gov (US) |
Summary
Funding opportunity RFA-AI-28-024. CFDA: 93.855
The buyer, the value, the full description and the link to the official notice are available with a free account.